Each box contain 10 Alu-Alu strips of 10 tablets

1. is a third-generation cephalosporin, inhibits bacterial cell wall synthesis, impeding bacterial growth. Ofloxacin is a fluoroquinolone that targets bacterial DNA gyrase, disrupting DNA replication. We offer this product under the brand of Zoprox O  Tablet.

•  It is indicated for treating respiratory tract infections like bronchitis and community-acquired pneumonia.
• Effective against urinary tract infections, including cystitis and pyelonephritis, caused by susceptible bacteria.
•  Suitable for managing skin and soft tissue infections such as cellulitis and impetigo.

1. a third-generation cephalosporin interferes with bacterial cell wall synthesis. It binds to penicillin-binding proteins, disrupting the final stages of peptidoglycan formation, leading to weakened cell walls. This impairment results in bacterial cell lysis and death, particularly effective against gram-positive and gram-negative bacteria. Ofloxacin is a fluoroquinolone, Ofloxacin targets bacterial DNA gyrase, an enzyme vital for DNA replication. By inhibiting this process, Ofloxacin disrupts bacterial DNA synthesis, preventing further replication and causing bacterial cell death.

Absorption:

Its constituents are well-absorbed orally. Cefpodoxime exhibits peak concentrations in 2-3 hours, while Ofloxacin reaches its peak within 1-2 hours, with absorption unaffected by food intake.

Distribution:

Both components have wide tissue distribution. Cefpodoxime penetrates respiratory tissues, urine, and skin, while Ofloxacin distributes into various tissues, including lung, kidney, prostate, and skin.

Excretion:

Cefpodoxime is primarily eliminated unchanged in urine, and Ofloxacin undergoes both renal and non-renal excretion. With short half-lives, ZOPROX-O allows for convenient dosing intervals, ensuring effective and timely antibacterial action.

• Avoid in individuals with known hypersensitivity to Cefpodoxime, Ofloxacin, or related antibiotics.
• Contraindicated in patients with a history of tendon disorders associated with quinolone use.
• Use caution and consult a healthcare professional before use during pregnancy or breastfeeding due to potential risks to the fetus or infant.

• Use with caution in individuals with renal impairment, as dosage adjustments may be necessary.
• Patients with a history of seizures should be monitored closely during ZOPROX-O treatment.

• Caution against the development of superinfections, as with any antibiotic therapy, and prompt action if secondary infections occur.

The medical information on this website is provided as an information resource only. The information on this website is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider or a medical practitioner in understanding any information or in applying information that you might have come across, on this website. Please note that it dangerous to take any medication without doctor’s prescription or professional advice from a registered health practitioner. Do not use this information in place of a visit, consultation or advice of your healthcare providers.